| [1] |
|
| [2] |
ADDISON TGW. On a certain affection of the skin, vitiligo idea-α plana, β tuberosa with remarks and plates[J]. Guys Hosp Rep, 1851, 7: 265-276.
|
| [3] |
|
| [4] |
HARMS MH, de VEER RC, LAMMERS WJ, et al. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis[J]. Gut, 2020, 69(8): 1502-1509. DOI: 10.1136/gutjnl-2019-319057 |
| [5] |
LIERMANN GARCIA RF, EVANGELISTA GARCIA C, MCMASTER P, et al. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center[J]. Hepatology, 2001, 33(1): 22-27. DOI: 10.1053/jhep.2001.20894 |
| [6] |
BOSCH A, DUMORTIER J, MAUCORT-BOULCH D, et al. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence[J]. J Hepatol, 2015, 63(6): 1449-1458. DOI: 10.1016/j.jhep.2015.07.038 |
| [7] |
RONCA V, MANCUSO C, MILANI C, et al. Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis[J]. J Leukoc Biol, 2020, 108(2): 659-671. DOI: 10.1002/JLB.5MR0320-200R |
| [8] |
URNO K, AIBA Y, HITOMI Y, et al. Integrated GWAS and mRNA microarray analysis identified IFNG and CD40L as the central upstream regulators in primary biliary cholangitis[J]. Hepatol Commun, 2020, 4(5): 724-738. DOI: 10.1002/hep4.1497 |
| [9] |
BILZER M, ROGGEL F, GERBES AL. Role of Kupffer cells in host defense and liver disease[J]. Liver Int, 2006, 26(10): 1175-1186. DOI: 10.1111/j.1478-3231.2006.01342.x |
| [10] |
DAMBACH DM, WATSON LM, GRAY KR, et al. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse[J]. Hepatology, 2002, 35(5): 1093-1103. DOI: 10.1053/jhep.2002.33162 |
| [11] |
HAN XF. Expression level of TAM receptors signaling pathway in primary biliary cirrhosis and its regulatory mechanism in macrophage polarization[D]. Shanghai: Shanghai Jiaotong University, 2011. (in Chinese)
韩晓凤. 巨噬细胞极化在原发性胆汁性肝硬化中的作用[D]. 上海: 上海交通大学, 2011.
|
| [12] |
QIN BD. Expression level of TAM receptors signaling pathway in primary biliary cirrhosis and its regulatory mechanism in macrophage polarization[D]. Shanghai: The Second Military Medical University, 2016. (in Chinese)
秦保东. TAM信号通路在原发性胆汁性肝硬化患者中的表达水平及其对巨噬细胞极化的影响[D]. 上海: 第二军医大学, 2016.
|
| [13] |
FU HY, BAO WM, YANG CX, et al. Kupffer cells regulate natural killer cells via the NK group 2, Member D (NKG2D)/Retinoic Acid Early Inducible-1 (RAE-1) interaction and cytokines in a primary biliary cholangitis mouse model[J]. Med Sci Monit, 2020, 26: e923726.
|
| [14] |
SATO K, HALL C, GLASER S, et al. Pathogenesis of Kupffer cells in cholestatic liver injury[J]. Am J Pathol, 2016, 186(9): 2238-2247. DOI: 10.1016/j.ajpath.2016.06.003 |
| [15] |
OSAWA Y, SEKI E, ADACHI M, et al. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice[J]. Hepatology, 2010, 51(1): 237-245. DOI: 10.1002/hep.23262 |
| [16] |
TOMIYAMA T, YANG GX, ZHAO M, et al. The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis[J]. Cell Mol Immunol, 2017, 14(3): 276-284. DOI: 10.1038/cmi.2015.86 |
| [17] |
ALABRABA EB, LAI V, BOON L, et al. Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion[J]. Hepatology, 2008, 47(2): 552-562. http://www.ncbi.nlm.nih.gov/pubmed/17999420/ |
| [18] |
TEDESCO D, THAPA M, CHIN CY, et al. Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic γδ T-cell receptor-positive cells and pathogenesis of cholestatic liver disease[J]. Gastroenterology, 2018, 154(8): 2178-2193. DOI: 10.1053/j.gastro.2018.02.019 |
| [19] |
LI Y, TANG R, LEUNG P, et al. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases[J]. Autoimmun Rev, 2017, 16(9): 885-896. DOI: 10.1016/j.autrev.2017.07.002 |
| [20] |
YANG WX, TANG YM. Role of hepatic macrophages in the development and progression of primary biliary cholangitis[J]. J Clin Hepatol, 2020, 36(4): 936-939. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.04.051 |
| [21] |
WANG YQ, MAO JB, ZHOU MQ, et al. Polysaccharide from Phellinus Igniarius activates TLR4-mediated signaling pathways in macrophages and shows immune adjuvant activity in mice[J]. Int J Biol Macromol, 2019, 123: 157-166. DOI: 10.1016/j.ijbiomac.2018.11.066 |
| [22] |
COSOLA C, DE ANGELIS M, ROCCHETTI MT, et al. Beta-glucans supplementation associates with reduction in P-Cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals[J]. PLoS One, 2017, 12(1): e0169635. DOI: 10.1371/journal.pone.0169635 |
| [23] |
|
| [24] |
PAROLA M, ROBINO G. Oxidative stress-related molecules and liver fibrosis[J]. J Hepatol, 2001, 35(2): 297-306. DOI: 10.1016/S0168-8278(01)00142-8 |
| [25] |
GE X, ARRIAZU E, MAGDALENO F, et al. High mobility group Box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice[J]. Hepatology, 2018, 68(6): 2380-2404. DOI: 10.1002/hep.30093 |
| [26] |
NI HM, WOOLBRIGHT BL, WILLIAMS J, et al. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy[J]. J Hepatol, 2014, 61: 617-625. DOI: 10.1016/j.jhep.2014.04.043 |
| [27] |
LODDER J, DENAЁS T, CHOBERT MN, et al. Macrophage autophagy protects against liver fibrosis in mice[J]. Autophagy, 2015, 11(8): 1280-1292. DOI: 10.1080/15548627.2015.1058473 |
| [28] |
ALZAID F, LAGADEC F, ALBUQUERQUE M, et al. IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans[J]. JCI Insight, 2016, 1(20): e88689. http://europepmc.org/articles/PMC5135279 |
| [29] |
|
| [30] |
European Association for the Study of the Liver. EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172. DOI: 10.1016/j.jhep.2017.03.022 |
| [31] |
JING XD, YAO JN, LI YL, et al. Risk factors for hepatocellular cancer occurrence in patients with primary biliary cholangitis[J]. Chin J Clin Oncol, 2019, 46(16): 836-840. (in Chinese) DOI: 10.3969/j.issn.1000-8179.2019.16.719 |
| [32] |
|
| [33] |
WAIDMANN O, PLELI T, WEIGERT A, et al. Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis[J]. Sci Rep, 2020, 10(1): 16264. DOI: 10.1038/s41598-020-73387-4 |
| [34] |
WU H, ZHONG Z, WANG A, et al. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells[J]. Cancer Cell Int, 2020, 20: 266. DOI: 10.1186/s12935-020-01354-0 |
| [35] |
YOU Q, CHENG L, KEDL RM, et al. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells[J]. Hepatology, 2008, 48(3): 978-990. DOI: 10.1002/hep.22395 |
| [36] |
KUANG DM, ZHAO Q, PENG C, et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1[J]. J Exp Med, 2009, 206(6): 1327-1337. DOI: 10.1084/jem.20082173 |
| [37] |
LI H, WU K, TAO K, et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma[J]. Hepatology, 2012, 56(4): 1342-1351. DOI: 10.1002/hep.25777 |
DownLoad: